Clinical trial
Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of…
NCT00294385 · Central European Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00294385 |
|---|---|
| Title | Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine |
| Official title | A Randomized Phase III Study Comparing Concomitant Docetaxel Plus Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine in Anthracycline-Pretreated Metastatic or Locally Recurrent Breast Cancer Patients |
| Lead sponsor | Central European Cooperative Oncology Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Docetaxel, Gemcitabine |
| Enrollment | 430 |
| Start date | Jun 1, 2002 |
| Completion | Oct 1, 2005 |
| First posted | Feb 22, 2006 |
| Last update posted | Jun 23, 2011 |
| Countries | Austria, Bulgaria, Czechia, Israel, Lebanon, Poland, Slovakia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: